SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM shares are receiving attention following reports that Anthropic is the unnamed customer in its multi-year compute deal, alongside news of the company moving to acquire nearly full ownership of Northern Data. While some traders view these developments as a major structural shift toward becoming a significant AI infrastructure provider, others express skepticism regarding the company's profitability and the potential for future share dilution.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The community is debating the potential impact of slowing AI development after key industry leaders advocated for caution, leading to widespread uncertainty and bearish sentiment regarding current market valuations. Traders are also closely monitoring the intersection of rising energy costs, surging bond yields, and the upcoming Federal Reserve policy meeting as primary drivers for increased volatility.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

The Breakwave Tanker Shipping ETF is trending due to surging freight rates driven by ongoing geopolitical disruptions in the Strait of Hormuz and Red Sea, with traders closely monitoring tanker freight futures and supply chain impacts. While some investors view the asset as a lucrative hedge against Middle East instability, others express caution regarding its extreme volatility and the potential for a rapid price reversal should regional tensions ease.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as traders react to Chairman Larry Ellison's unexpected cancellation of a plan to sell up to 50 million shares, a move retail investors are interpreting as a signal of confidence that could pressure short sellers. While some traders remain cautious due to broader industry concerns over AI development pacing and Oracle's high capital expenditure, the sentiment among retail participants is largely bullish, with many anticipating a potential short squeeze.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as traders debate the stock's long-term growth potential and recent performance, with many expressing frustration over the lack of price appreciation despite strong quarterly earnings. The conversation is dominated by contrasting views on management's dilution strategy, the impact of macro factors like interest rates, and technical price action, with bears citing persistent stagnation while bulls emphasize the company's ecosystem growth and institutional accumulation.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is experiencing heightened volatility as traders debate whether the recent selloff is an overreaction to sector-wide concerns or a tactical price manipulation. The discussion is heavily influenced by divergent reactions to recent conference updates and the upcoming ex-dividend date, with many traders framing the stock as an undervalued defensive play in an uncertain macro environment.

Anthropic

Anthropic is trending following reports that the company has confidentially filed for an IPO, fueling intense speculation regarding its potential valuation and market impact. The community conversation remains heavily focused on the company's competitive position against OpenAI, its massive infrastructure investments, and its recent high-profile partnerships.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors respond to escalating tensions in the Middle East, specifically reports of damage to Saudi Arabia's East-West pipeline and increased conflict in the Strait of Hormuz. While some traders are bullish on potential supply disruptions driving prices higher, others are skeptical, debating the impact of upcoming geopolitical developments and speculating on potential market manipulation.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as traders debate the potential market impact of prominent AI leaders calling for a slowdown in development and safety regulation. Investors are also monitoring broader macro pressures, including rising bond yields and escalating oil prices ahead of the upcoming Federal Reserve policy meeting.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending following its recent completion of the Serra Verde Group merger and investor optimism regarding government-backed funding for domestic magnet manufacturing. While some traders are bullish on the company's long-term role in national security and supply chain independence, others are concerned about potential share dilution and recent price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The discussion is primarily focused on the significant potential of ivonescimab as a competitor to Merck's Keytruda, bolstered by recent clinical trial data and strong insider buying, while investors remain cautious about the company's financial runway ahead of the November 14 PDUFA date.

Dow, S&P 500, Nasdaq Futures Decline Amid AI Concerns, Rising Oil Prices Ahead Of Fed Rate Week: RUM,  ORCL, SMMT, USO Stocks In Focus

Equity

Rising oil prices amid the ongoing conflict with Iran have pressured long-term bond yields and also impacted stock markets ahead of the Fed’s September policy meeting. 

Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akesos HARMONi-2 Study Conducted in China

Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. announced that updated data, including overall survival (OS), from the randomized, double-blind Phase III HARMONi-2 trial featuring the novel, potential first-in-class investigational bispecific antibody ivonescimab is...

SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China

Summit Therapeutics stock jumps 17% after ivonescimab showed a significant overall survival benefit over Keytruda in a China phase III lung cancer study.

Summit Therapeutics, HUTCHMED, Tesla And Other Big Stocks Moving Higher On Thursday

U.S. stocks rose Thursday; Summit Therapeutics jumped 10.1% after Phase III results, while Snowflake and other stocks rallied.read more...

Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study Conducted by Akeso in China

Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. announced positive overall survival (OS) results from the randomized, double-blind Phase III HARMONi-2 study evaluating ivonescimab monotherapy against pembrolizumab monotherapy in patients with locally advanced or...

Why Is Corcept (CORT) Down 1.2% Since Last Earnings Report?

Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

RVMD Secures FDA Win, Gets Nod for Rasonque in Pancreatic Cancer  

Rasonque wins FDA approval for pancreatic cancer, giving Revolution Medicines its first marketed product and a commercial foothold.

SMMT Rises on Akeso's Win in Phase III Biliary Tract Cancer Study

Summit gains as positive HARMONi-GI1 data show ivonescimab's OS benefit in biliary tract cancer, expanding its potential beyond NSCLC.

Summit’s Global Lung Cancer Trials Gain Credibility After Akeso’s Phase 3 Data, Says Guggenheim

Akeso reported positive late-stage data for Ivonescimab, a drug that Summit Therapeutics holds the rights to develop and sell outside China.

Summit Therapeutics Partner Highlights Positive Interim Data Milestone for Lead Cancer Therapy

Summit Therapeutics partner Akeso Phase 3 HARMONi-GI1 trial shows ivonescimab outperforms durvalumab in overall survival for advanced biliary tract cancer.read more...

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Bullish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits Polls

Traders are highlighting clinical trial data where ivonescimab significantly outperformed Keytruda in overall survival metrics.

Focus is shifting toward key upcoming trial milestones and result presentations at the World Lung Conference.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SMMT News